Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of the potassium channel gene KCNK2 in major depressive disorder.

Psychiatry research - 28 Feb 2015

Congiu Chiara, Minelli Alessandra, Bonvicini Cristian, Bortolomasi Marco, Sartori Riccardo, Maj Carlo, Scassellati Catia, Maina Giuseppe, Trabucchi Luigi, Segala Matilde, Gennarelli Massimo

Abstract excerpt

Six single nucleotide polymorphisms (SNPs) of the KCNK2 gene were investigated for their association with major depressive disorder (MDD) and treatment efficacy in 590 MDD patients and 441 controls. The A homozygotes of rs10779646 were significantly more frequent in patients than controls whereas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Antidepressive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Depressive Disorder, Major

Share to Genetic Predisposition to Disease

Share to Genotype

Share to Polymorphism, Genetic

Share to Polymorphism, Single Nucleotide

Share to Potassium Channels, Tandem Pore Domain

Source

Identifiers

PMID: 25535009
DOI: 10.1016/j.psychres.2014.11.061

Genes

KCNK2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25535009-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of the potassium channel gene KCNK2 in major depressive disorder.PMID 25535009Read ↗

Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.Semantic proximity Read ↗

Pharmacogenetics studies in STAR*D: strengths, limitations, and results.Semantic proximity Read ↗

Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study.Semantic proximity Read ↗

Pharmacogenomics with antidepressants in the STAR*D study.Semantic proximity Read ↗

Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.Semantic proximity Read ↗

The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.Semantic proximity Read ↗

Genome-wide association study and polygenic risk score analysis of esketamine treatment response.Semantic proximity Read ↗

A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes.Semantic proximity Read ↗

A molecular pathway analysis of the glutamatergic-monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment.Semantic proximity Read ↗

Analysis of SNP profiles in patients with major depressive disorder.Semantic proximity Read ↗

DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy.Semantic proximity Read ↗

Common variants in FKBP5 gene and major depressive disorder (MDD) susceptibility: a comprehensive meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.